Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism

The study is designed to answer the following questions:

1. Is hypogonadism a cause for the metabolic syndrome ? 2. What is the effect of testosterone replacement on the metabolic parameters ?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypogonadism Endocrine System Diseases Glucose Metabolism Disorders Gonadal Disorders Hyperinsulinism Insulin Resistance Metabolic Diseases Metabolic Syndrome Nutritional and Metabolic Diseases

Age range

18 year–26 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 4

Primary location

Gulhane School of Medicine

Ankara, 06018, Turkey (Türkiye)

About this study

This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2002-2009.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men
Congenital hypogonadism
Treatment Naive

Exclusion criteria

Previous history of androgen replacement
Hypertension
Diabetes mellitus

Treatment and study plan

Testosteron

Drug

Testosteron 250mg injection per 3-4 weeks for 6 months

Other names: Sustanon 250mg

Sponsors and collaborators

Lead sponsor

Gulhane School of Medicine

Other

Registry information

Official study title

Phase 4 Study of About the Effect of Testosterone Treatment on the Components of Metabolic Syndrome

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Jul 12, 2010
Registry last updated: Jul 12, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed